PRODERMIS PROSCULPT — Redefining the Science of Dermal Fillers
Prodermis Prosculpt is the first hybrid dermal filler to combine cross-linked Hyaluronic Acid with Polynucleotides in a patented formulation. This synergy delivers immediate volumisation and lift alongside progressive dermal regeneration, superior rheology, reduced injection force, and extended longevity of up to 56 weeks — redefining filler performance and clinical outcomes.
PRODERMIS at IMCAS Paris 2026: Introducing PROSCULPT™ and the New PRODERMIS Skincare Line
We’re delighted to announce our participation in IMCAS Paris 2026, one of the world’s most prestigious events in dermatology, plastic surgery, and aesthetic science. Taking place at the Palais des Congrès de Paris, this annual congress gathers global leaders, innovators, and practitioners to explore the future of medical aesthetics. Building on a year of exceptional progress, PRODERMIS returns to […]